The GARDP Foundation (known as GARDP) and the privately-owned, global biopharmaceutical company Debiopharm today announced that they have entered into a collaboration and license agreement to pursue ...
Validated clinical efficacy and scalable manufacturing propel exosomes from research discovery to commercial therapeutics.
Zai Lab Limited today provided an update on the Company's 2026 strategic priorities and clinical development progress. These updates will be discussed as part of the Company's presentation at the 44th ...
Sensorineural hearing loss (SNHL) is a highly prevalent sensory disorder globally, affecting over 1.5 billion people, with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback